Avelumab Program Rollover Study
Public ClinicalTrials.gov record NCT03815643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to monitor the safety and tolerability of avelumab in participants with solid tumors who continue treatment with avelumab under the same treatment regimen as in the parent avelumab study.
Study identification
- NCT ID
- NCT03815643
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 205 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 22, 2019 (Actual)
- Primary completion
- Nov 24, 2026 (Estimated)
- Completion
- Nov 24, 2026 (Estimated)
- Last update posted
- Sep 22, 2026
2019 – 2026
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth Research Institute | Scottsdale | Arizona | 85258 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| University of California Davis Health System - Comprehensive Cancer Center | Sacramento | California | 95817 | — |
| Providence Medical Foundation | Santa Rosa | California | 95403 | — |
| St Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| Norwalk Hospital - The Whittingham Cancer Center | Norwalk | Connecticut | 06850 | — |
| Hematology - Oncology Associates of the Treasure Coast - Hematology-Oncology Associates of Treasure Coast | Port Saint Lucie | Florida | 34952 | — |
| Northwest Georgia Oncology Centers | Marietta | Georgia | 30060 | — |
| Maryland Oncology Hematology, P.A. | Rockville | Maryland | 20850 | — |
| Michigan State University | Lansing | Michigan | 48910 | — |
| Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | — |
| Kansas City Research Institute, LLC - Phase I Unit | Kansas City | Missouri | 64131 | — |
| University of Cincinnati - PARENT | Cincinnati | Ohio | 45229 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| Oncology/Hematology Care Clinical Trials, LLC | Cincinnati | Ohio | 45242 | — |
| OSU - James Comprehensive Cancer Center | Columbus | Ohio | 43210-1228 | — |
| Oregon Health & Science University | Portland | Oregon | 97201 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29425 | — |
| Greenville Hospital System University Medical Center (ITOR) - Upstate Affiliate Organization | Greenville | South Carolina | 29605 | — |
| The West Clinic | Germantown | Tennessee | 38138 | — |
| SCRI - Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-8857 | — |
| Oncology Consultants, P.A. | Houston | Texas | 77030 | — |
| Henry Ford Hospital | San Antonio | Texas | 78229 | — |
| University of Vermont Medical Center - Fletcher Allen Gastroenterology | Burlington | Vermont | 05401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03815643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 22, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03815643 live on ClinicalTrials.gov.